Exchange: NASDAQ·Updated 07:30 PM EDT

FTH Faeth Therapeutics Inc.

$17.08
$3.02
(15.03%)
Today
Closed $17.08
$0.00
(0.00%)
After Hours
EarningsNov 3
Mkt Cap$441.35M
Vol353,709.00

About FTH

Faeth Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Austin, TX.
40

Bearish Sentiment

How do you feel about FTH?

Quantumup
Citizens reiterated $FTH Market Outperform-$51 after Faeth highlighted the rationale and benefits of multi-node inhibition w/ PIKTOR (serabelisib [PI3Kα] and sapanisertib [mTORC1/2]) during the Co's first virtual KOL event. $CELC $RLAY NVS RHHBY AZN Citizens said -- We continue to be impressed by the asset and potential clinical profile, and view the upcoming update in endometrial cancer as a major milestone for PIKTOR.
1
focafoca99
$FTH launched a preclinical poster on PIKTOR at ESMO 2026, showcasing data in HR+/HER2- breast cancer models.

Advertisement|Remove ads.